Workshop: Kinase Ligand Design

webinar

Thu, 01 Feb 2024, 16:00 CET (Berlin)

Dr. Alexander Neumann, BioSolveIT

Workshop: Kinase Ligand Design

Kinases stand out as a popular focus in drug development. Their popularity is evident from the numerous FDA approvals granted to compounds targeting these specific proteins. The associated design process often integrates computational approaches such as molecular modeling and structure-based drug design, reflecting the dynamic and evolving landscape of kinase-targeted drug development.

This BioSolveIT workshop is dedicated to elucidating the basics of selective kinase inhibitor design, as well as the application of advanced techniques to optimize lead structures. Encompassing both the 3D structure-based and the 2D ligand-based realms, we will present and discuss several examples illustrating idea generation methods for hinge binders and the adjacent core regions. These methods will include fragment-based growing (FBDD), scaffold hopping, Chemical Space exploration involving trillions of possibilities, and various other strategies facilitated by BioSolveIT tools.

Drug discovery beginners, veterans, and medicinal chemistry enthusiasts are invited to join this highly informative workshop and the subsequent discussion.

Participants can request a certificate of attendance to confirm their completion of the event to furthering their knowledge and skills in the specified subject matter.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on